Article Quantitative Evaluation of Nucleic Acid Degradability of Copper Alloy Surfaces and Its Correlation to Antibacterial Activity

Akiko Yamamoto SAMURAI ORCID (National Institute for Materials Science) ; Shinji Tanaka ; Keiichiro Ohishi

Collection

Citation
Akiko Yamamoto, Shinji Tanaka, Keiichiro Ohishi. Quantitative Evaluation of Nucleic Acid Degradability of Copper Alloy Surfaces and Its Correlation to Antibacterial Activity. Antibiotics-Basel. 2021, 10 (12), 1439-1439. https://doi.org/10.3390/antibiotics10121439
SAMURAI

Description:

(abstract)

Copper (Cu) and its alloys have bactericidal activity known as “contact killing” with degradation of nucleic acids inside the bacteria, which is beneficial to inhibit horizontal gene transfer (HGF). In order to understand the nucleic acid degradability of Cu and its alloy surfaces, we developed a new in vitro method to quantitatively evaluate it by a swab method under a “dry” condition and compared it with that of commercially available antibacterial materials such as antibacterial stainless steel, pure silver, and antibacterial resins. As a result, only Cu and its alloys showed continuous degradation of nucleic acids for up to 6 h of contact time. The nucleic acid degradability levels of the Cu alloys and other antibacterial materials correlate to their antibacterial activities evaluated by a film method referring to JIS Z 2801:2012 for Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria. Nucleic acid degradation by copper (I) and (II) chlorides was confirmed at the ranges over 10 mM and 1–20 mM, respectively, suggesting that the copper ion release may be responsible for the degradation of the nucleic acids on Cu and its alloy surfaces. In conclusion, the higher Cu content in the alloys gave higher nucleic acid degradability and higher antibacterial activities.

Rights:

Keyword: antimicrobial activities, antibacterial test, copper and copper alloys, DNA degradability, a swab method

Date published: 2021-11-24

Publisher: MDPI AG

Journal:

  • Antibiotics-Basel (ISSN: 20796382) vol. 10 issue. 12 p. 1439-1439

Funding:

Manuscript type: Publisher's version (Version of record)

MDR DOI:

First published URL: https://doi.org/10.3390/antibiotics10121439

Related item:

Other identifier(s):

Contact agent:

Updated at: 2024-01-25 09:56:33 +0900

Published on MDR: 2024-01-25 12:30:18 +0900

Filename Size
Filename antibiotics-10-01439-v2.pdf (Thumbnail)
application/pdf
Size 2.08 MB Detail
Filename antibiotics-1457295-supplementary.pdf
application/pdf
Size 158 KB Detail